Ryan Specialty Holdings, Inc.

RYANNYSECIK 1849253Financial / Insurance Brokersfiscal year ends December26 quarters since 2020

Revenue, Q3 FY2026
$775M
+4.8% on Q3 FY2025
Net income
$37M
+18.0% on Q3 FY2025
Free cash flow
$181M
+8.4% on Q3 FY2025
Diluted EPS
$0.30
+25.0% on Q3 FY2025
Revenue, TTM
$3.2B
trailing four quarters
Net margin, TTM
3.3%
net income $105M
Free cash flow, TTM
$569M
$570M less $2M capex
Cash and equivalents
$169M
long-term debt $3.6B, Sep 30, 2026
Shares, 12-month change
−5.1%
121M diluted weighted shares (no single count on the cover), Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$64M
1.1% of market value
Market value
$5.7B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 30, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Ryan Specialty Holdings, Inc. reported revenue of $775M, +4.8% on Q3 FY2025, and net income of $37M (+18.0%). Operating margin was 18.2%. Free cash flow, operating cash flow less capital expenditures, was $181M ($181M less $0). Diluted earnings per share were $0.30.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

RYAN daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $46.43 · H $47.78 · L $45.69 · C $46.89 · +1.60% on the dayOver the range: −17.53%, Nov 14, 2025 to Nov 13, 2026
$28$36$44$52$61Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 30, 2026.

Revenue and net incomeRevenueNet income
−$250M$0$250M$500M$750M$1.0BQ4'22, Revenue: $422MQ4'22, Net income: $18MQ4'22Q1'23, Net income: $13MQ1'23Q2'23, Net income: $30MQ2'23Q3'23, Net income: −$5MQ3'23Q4'23, Net income: $23MQ4'23Q1'24, Revenue: $538MQ1'24, Net income: $17MQ1'24Q2'24, Revenue: $680MQ2'24, Net income: $47MQ2'24Q3'24, Revenue: $588MQ3'24, Net income: $18MQ3'24Q4'24, Revenue: $649MQ4'24, Net income: $14MQ4'24Q1'25, Revenue: $676MQ1'25, Net income: −$28MQ1'25Q2'25, Revenue: $841MQ2'25, Net income: $52MQ2'25Q3'25, Revenue: $740MQ3'25, Net income: $31MQ3'25Q4'25, Revenue: $738MQ4'25, Net income: $8MQ4'25Q1'26, Revenue: $783MQ1'26, Net income: $18MQ1'26Q2'26, Revenue: $903MQ2'26, Net income: $42MQ2'26Q3'26, Revenue: $775MQ3'26, Net income: $37MQ3'26−$250M$0$250M$500M$750M$1.0BQ4'22, Revenue: $422MQ4'22, Net income: $18MQ4'22Q1'23, Net income: $13MQ1'23Q2'23, Net income: $30MQ2'23Q3'23, Net income: −$5MQ3'23Q4'23, Net income: $23MQ4'23Q1'24, Revenue: $538MQ1'24, Net income: $17MQ1'24Q2'24, Revenue: $680MQ2'24, Net income: $47MQ2'24Q3'24, Revenue: $588MQ3'24, Net income: $18MQ3'24Q4'24, Revenue: $649MQ4'24, Net income: $14MQ4'24Q1'25, Revenue: $676MQ1'25, Net income: −$28MQ1'25Q2'25, Revenue: $841MQ2'25, Net income: $52MQ2'25Q3'25, Revenue: $740MQ3'25, Net income: $31MQ3'25Q4'25, Revenue: $738MQ4'25, Net income: $8MQ4'25Q1'26, Revenue: $783MQ1'26, Net income: $18MQ1'26Q2'26, Revenue: $903MQ2'26, Net income: $42MQ2'26Q3'26, Revenue: $775MQ3'26, Net income: $37MQ3'26−$250M$0$250M$500M$750M$1.0BQ4'22, Revenue: $422MQ4'22, Net income: $18MQ1'23, Net income: $13MQ1'23Q2'23, Net income: $30MQ3'23, Net income: −$5MQ3'23Q4'23, Net income: $23MQ1'24, Revenue: $538MQ1'24, Net income: $17MQ1'24Q2'24, Revenue: $680MQ2'24, Net income: $47MQ3'24, Revenue: $588MQ3'24, Net income: $18MQ3'24Q4'24, Revenue: $649MQ4'24, Net income: $14MQ1'25, Revenue: $676MQ1'25, Net income: −$28MQ1'25Q2'25, Revenue: $841MQ2'25, Net income: $52MQ3'25, Revenue: $740MQ3'25, Net income: $31MQ3'25Q4'25, Revenue: $738MQ4'25, Net income: $8MQ1'26, Revenue: $783MQ1'26, Net income: $18MQ1'26Q2'26, Revenue: $903MQ2'26, Net income: $42MQ3'26, Revenue: $775MQ3'26, Net income: $37MQ3'26

Net income losses drawn in red.

Free cash flow
−$200M$0$200M$400MQ4'22, Free cash flow: $177MQ4'22Q1'23Q2'23Q3'23Q4'23Q1'24, Free cash flow: −$117MQ1'24Q2'24, Free cash flow: $271MQ2'24Q3'24, Free cash flow: $101MQ3'24Q4'24, Free cash flow: $260MQ4'24Q1'25, Free cash flow: −$143MQ1'25Q2'25, Free cash flow: $354MQ2'25Q3'25, Free cash flow: $167MQ3'25Q4'25, Free cash flow: $263MQ4'25Q1'26, Free cash flow: −$167MQ1'26Q2'26, Free cash flow: $291MQ2'26Q3'26, Free cash flow: $181MQ3'26−$200M$0$200M$400MQ4'22, Free cash flow: $177MQ4'22Q1'23Q2'23Q3'23Q4'23Q1'24, Free cash flow: −$117MQ1'24Q2'24, Free cash flow: $271MQ2'24Q3'24, Free cash flow: $101MQ3'24Q4'24, Free cash flow: $260MQ4'24Q1'25, Free cash flow: −$143MQ1'25Q2'25, Free cash flow: $354MQ2'25Q3'25, Free cash flow: $167MQ3'25Q4'25, Free cash flow: $263MQ4'25Q1'26, Free cash flow: −$167MQ1'26Q2'26, Free cash flow: $291MQ2'26Q3'26, Free cash flow: $181MQ3'26−$200M$0$200M$400MQ4'22, Free cash flow: $177MQ1'23Q3'23Q1'24, Free cash flow: −$117MQ1'24Q2'24, Free cash flow: $271MQ3'24, Free cash flow: $101MQ3'24Q4'24, Free cash flow: $260MQ1'25, Free cash flow: −$143MQ1'25Q2'25, Free cash flow: $354MQ3'25, Free cash flow: $167MQ3'25Q4'25, Free cash flow: $263MQ1'26, Free cash flow: −$167MQ1'26Q2'26, Free cash flow: $291MQ3'26, Free cash flow: $181MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3B$4BQ4'22, Cash and equivalents: $993MQ4'22, Long-term debt: $2.0BQ4'22Q1'23, Cash and equivalents: $1.5BQ1'23, Long-term debt: $2.0BQ1'23Q2'23, Cash and equivalents: $2.0BQ2'23, Long-term debt: $1.9BQ2'23Q3'23, Cash and equivalents: $754MQ3'23, Long-term debt: $1.9BQ3'23Q4'23, Cash and equivalents: $839MQ4'23, Long-term debt: $1.9BQ4'23Q1'24, Cash and equivalents: $665MQ1'24, Long-term debt: $1.9BQ1'24Q2'24, Cash and equivalents: $612MQ2'24, Long-term debt: $1.9BQ2'24Q3'24, Cash and equivalents: $235MQ3'24, Long-term debt: $2.6BQ3'24Q4'24, Cash and equivalents: $540MQ4'24, Long-term debt: $3.2BQ4'24Q1'25, Cash and equivalents: $204MQ1'25, Long-term debt: $3.7BQ1'25Q2'25, Cash and equivalents: $173MQ2'25, Long-term debt: $3.4BQ2'25Q3'25, Cash and equivalents: $153MQ3'25, Long-term debt: $3.3BQ3'25Q4'25, Cash and equivalents: $158MQ4'25, Long-term debt: $3.3BQ4'25Q1'26, Cash and equivalents: $155MQ1'26, Long-term debt: $3.5BQ1'26Q2'26, Cash and equivalents: $140MQ2'26, Long-term debt: $3.6BQ2'26Q3'26, Cash and equivalents: $169MQ3'26, Long-term debt: $3.6BQ3'26$0$1B$2B$3B$4BQ4'22, Cash and equivalents: $993MQ4'22, Long-term debt: $2.0BQ4'22Q1'23, Cash and equivalents: $1.5BQ1'23, Long-term debt: $2.0BQ1'23Q2'23, Cash and equivalents: $2.0BQ2'23, Long-term debt: $1.9BQ2'23Q3'23, Cash and equivalents: $754MQ3'23, Long-term debt: $1.9BQ3'23Q4'23, Cash and equivalents: $839MQ4'23, Long-term debt: $1.9BQ4'23Q1'24, Cash and equivalents: $665MQ1'24, Long-term debt: $1.9BQ1'24Q2'24, Cash and equivalents: $612MQ2'24, Long-term debt: $1.9BQ2'24Q3'24, Cash and equivalents: $235MQ3'24, Long-term debt: $2.6BQ3'24Q4'24, Cash and equivalents: $540MQ4'24, Long-term debt: $3.2BQ4'24Q1'25, Cash and equivalents: $204MQ1'25, Long-term debt: $3.7BQ1'25Q2'25, Cash and equivalents: $173MQ2'25, Long-term debt: $3.4BQ2'25Q3'25, Cash and equivalents: $153MQ3'25, Long-term debt: $3.3BQ3'25Q4'25, Cash and equivalents: $158MQ4'25, Long-term debt: $3.3BQ4'25Q1'26, Cash and equivalents: $155MQ1'26, Long-term debt: $3.5BQ1'26Q2'26, Cash and equivalents: $140MQ2'26, Long-term debt: $3.6BQ2'26Q3'26, Cash and equivalents: $169MQ3'26, Long-term debt: $3.6BQ3'26$0$1B$2B$3B$4BQ4'22, Cash and equivalents: $993MQ4'22, Long-term debt: $2.0BQ1'23, Cash and equivalents: $1.5BQ1'23, Long-term debt: $2.0BQ1'23Q2'23, Cash and equivalents: $2.0BQ2'23, Long-term debt: $1.9BQ3'23, Cash and equivalents: $754MQ3'23, Long-term debt: $1.9BQ3'23Q4'23, Cash and equivalents: $839MQ4'23, Long-term debt: $1.9BQ1'24, Cash and equivalents: $665MQ1'24, Long-term debt: $1.9BQ1'24Q2'24, Cash and equivalents: $612MQ2'24, Long-term debt: $1.9BQ3'24, Cash and equivalents: $235MQ3'24, Long-term debt: $2.6BQ3'24Q4'24, Cash and equivalents: $540MQ4'24, Long-term debt: $3.2BQ1'25, Cash and equivalents: $204MQ1'25, Long-term debt: $3.7BQ1'25Q2'25, Cash and equivalents: $173MQ2'25, Long-term debt: $3.4BQ3'25, Cash and equivalents: $153MQ3'25, Long-term debt: $3.3BQ3'25Q4'25, Cash and equivalents: $158MQ4'25, Long-term debt: $3.3BQ1'26, Cash and equivalents: $155MQ1'26, Long-term debt: $3.5BQ1'26Q2'26, Cash and equivalents: $140MQ2'26, Long-term debt: $3.6BQ3'26, Cash and equivalents: $169MQ3'26, Long-term debt: $3.6BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 30, 2026.

Ryan Specialty Holdings, Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 30, 2026Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue775903783738740841676649+4.8%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative107119109123118107106105−9.0%
Operating income1411809592111191100109+27.1%
Other income (expense)10100004+95.0%
Pretax income961314745601385169+60.8%
Income tax822713(3)135526+391.0%
Net income37421883152(28)14+18.0%
Diluted EPS ($)0.300.330.13—0.240.41(0.22)—+25.0%
Diluted shares (millions)121131137—128126125——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 30, 2026.

Ryan Specialty Holdings, Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 30, 2026Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents169140155158153173204540+10.0%
Short-term investments—————————
Total current assets5,7866,6435,5795,0604,4475,2664,6094,789+30.1%
Total assets11,04411,96711,01210,5649,85210,6269,8909,650+12.1%
Total current liabilities5,7546,6565,4565,1894,4575,2334,3994,549+29.1%
Long-term debt3,6343,5713,5343,2913,3493,4103,6533,231+8.5%
Total debt3,6763,6333,5693,3523,3913,4723,6893,283+8.4%
Total liabilities10,14310,9509,7939,3108,6209,4448,8338,552+17.7%
Stockholders’ equity447509636648630610543628−29.1%
Shares outstanding (millions)—————————

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 30, 2026.

Ryan Specialty Holdings, Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 30, 2026Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 1, 2026Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow181293(167)263170354(143)260+6.9%
Capital expenditures02002010−100.0%
Free cash flow (CFO − capex)181291(167)263167354(143)260+8.4%
Depreciation and amortization—————————
Share repurchases15026040—000——
Dividends paid1617171615151514+2.6%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 13, 2026.

Income statement

Ryan Specialty Holdings, Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 13, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 16, 2022FY2020ended Dec 31, 2020filed Sep 2, 2021FY2019ended Dec 31, 2019filed Sep 2, 2021
Revenue2,9952,4562,0271,7121,4331,018765
Cost of revenue———————
Gross profit———————
Research and development———————
Selling, general and administrative453352276197139107118
Operating income494428359290187159101
Other income (expense)1(15)(10)(5)(45)(32)3
Pretax income293273238179627968
Income tax79434316595
Net income63956161666864
Diluted EPS ($)0.470.710.520.57(0.07)——
Diluted shares (millions)138133126109106——

Balance sheet

Ryan Specialty Holdings, Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 13, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 16, 2022FY2020ended Dec 31, 2020filed Sep 2, 2021FY2019ended Dec 31, 2019filed Sep 2, 2021
Cash and equivalents1585408399931,140896402
Short-term investments———————
Total current assets5,0604,7894,3363,8943,0112,493—
Total assets10,5649,6507,2476,3845,4594,529—
Total current liabilities5,1894,5493,7443,1342,9182,482—
Long-term debt3,2913,2311,9441,9521,5671,566—
Total debt3,3523,2831,9711,9771,5901,585—
Total liabilities9,3108,5526,2685,5664,8644,219—
Stockholders’ equity648628560478———
Shares outstanding (millions)———————

Cash flow statement

Ryan Specialty Holdings, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 13, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 16, 2022FY2020ended Dec 31, 2020filed Sep 2, 2021FY2019ended Dec 31, 2019filed Sep 2, 2021
Operating cash flow644515477336273135150
Capital expenditures300834350
Free cash flow (CFO − capex)641515477328(70)130149
Depreciation and amortization28716811610911368—
Share repurchases———————
Dividends paid618000———

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$6M
3 sales by 2 insiders; officers and directors $6M
Bought, twelve months
$6M
9 purchases by 6 insiders; officers and directors $6M
Sold, twelve months
$239M
6 sales by 5 insiders; officers and directors $239M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 10, 2026Wuller Benjamin MIlesCEO RSUMoption exercise50,000$0.00—348,480Nov 12, 2026
Nov 10, 2026Wuller Benjamin MIlesCEO RSUMoption exercise50,000$0.00—144,095Nov 12, 2026
Nov 10, 2026Wuller Benjamin MIlesCEO RSUMopen-market sale50,000$47.18$2M94,095Nov 12, 2026
Nov 10, 2026Wuller Benjamin MIlesCEO RSUMgift7,577$0.00—86,518Nov 12, 2026
Nov 9, 2026Wuller Benjamin MIlesCEO RSUMoption exercise40,000$0.00—398,480Nov 12, 2026
Nov 9, 2026Wuller Benjamin MIlesCEO RSUMoption exercise40,000$0.00—144,095Nov 12, 2026
Nov 9, 2026Wuller Benjamin MIlesCEO RSUMopen-market sale50,000$47.31$2M94,095Nov 12, 2026
Sep 8, 2026Mulshine Brendan MartinCo-President and CROopen-market sale40,000$40.51$2M75,366Sep 9, 2026
Sep 4, 2026Mulshine Brendan MartinCo-President and CROconversion40,000$0.00—604,235Sep 9, 2026
Sep 4, 2026Mulshine Brendan MartinCo-President and CROconversion40,000$0.00—115,366Sep 9, 2026
Aug 14, 2026Cortezi Nicholas DominicDirectorotherindirect2M$0.00—2MAug 18, 2026
Aug 14, 2026Cortezi Nicholas DominicDirectorotherindirect313,116$0.00—313,116Aug 18, 2026
Aug 13, 2026Conklin MichaelEVP & CHROopen-market sale2,043$42.26$86K8,153Aug 14, 2026
Aug 10, 2026Bienen Henry SDirectorgiftindirect3,000$0.00—24,795Aug 12, 2026
Jul 22, 2026Hamilton Janice MChief Financial Officeroption exercise5,821——20,395Jul 24, 2026
Jul 22, 2026Hamilton Janice MChief Financial Officertax withholding1,706$40.89$70K18,689Jul 24, 2026
Jun 12, 2026Kuczinski Anthony JDirectoropen-market buy500$35.77$18K13,072Jun 15, 2026
Jun 11, 2026Kuczinski Anthony JDirectoropen-market buy2,500$34.83$87K12,572Jun 15, 2026
Jun 10, 2026Rogers John W JRDirectoropen-market buy7,500$35.16$264K117,933Jun 11, 2026
Jun 5, 2026Ryan Patrick GExecutive Chairman, Director, 10% owneropen-market buyindirect120,000$32.50$4M14MJun 8, 2026
Jun 3, 2026Hamilton Janice MChief Financial Officeropen-market buy6,300$31.79$200K14,574Jun 4, 2026
Jun 3, 2026Katz Mark StephenEVP & General Counselopen-market buy3,215$31.07$100K4,332Jun 4, 2026
May 29, 2026Bienen Henry SDirectorgiftindirect2,700$0.00—27,795Jun 1, 2026
May 28, 2026Bienen Henry SDirectorgift5,757$0.00—0Jun 1, 2026
May 28, 2026Bienen Henry SDirectorgiftindirect5,757$0.00—30,495Jun 1, 2026

Full insider history for Ryan Specialty Holdings, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
RYAN SPECIALTY HOLDINGS, INC., CIK 1849253 on EDGAR
Extract generated
November 16, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: revenue FY2023
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2024
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total debt: LongTermDebt, combined, noncurrent+DebtCurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets
Free cash flow (CFO − capex): not filed
Depreciation and amortization: not filed
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/RYAN.json